Silicosis: Clinical Trials

19 trials for Silicosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 9 unknown, 1 not yet recruiting. 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Completed 1
Phase 12Completed 2
Early Phase 11Unknown 1
Not applicable1Completed 1
Phase 31Completed 1

Follow Silicosis: new trials by email Literature Review of Silicosis trials Research Report on Silicosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
COPD, Interstitial Pneumonia
Not yet recruitingZhejiang University2502025-04-222025-04-22
Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania
No intervention - Silicosis, Tuberculosis
UnknownNational Heart and Lung Institute14002024-03-112024-05-16
Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil
Silica 12CH - Silicosis
Early Phase 1UnknownHOHM Foundation1002024-03-012024-02-28
Reducing Silica Exposure Among Brick Kiln Workers in Nepal
N95 Respirator, Protective Eyewear, Baseline Survey - Silicosis
Not applicableCompletedJohns Hopkins University982024-01-242024-06-24
The SHIELD Study-silicosis
Silicosis
UnknownThe University of Queensland1202022-08-162022-09-21
Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials
questionnaire, KAP - Silicosis, Silicotic Fibrosis (Massive) of Lung
UnknownSamuel Hatfield9952022-07-312022-09-22
The SHIELD Whole Lung Lavage Study
Whole Lung Lavage - Silicosis
UnknownThe University of Queensland302022-06-012022-06-02
KAP TB in Senior Management Officials of Companies With Increased Silica Exposure
TB - Tuberculosis, Silicosis
CompletedCentre for Infectious Disease Research in Zambia1182022-02-022026-08-06
Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis
Pirfenidone Oral Tablet - Silicosis, Progressive Massive Fibrosis
Phase 2UnknownInstituto de investigación e innovación biomédica de Cádiz182021-11-152022-01-13
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Nintedanib 150 MG [Ofev] - Pneumoconiosis Coal, Asbestosis
Phase 2UnknownHoldsworth House Medical Practice1002020-10-092021-02-10
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
Tuberculosis test, Chest X-ray, Pulmonary Function Test - Silicosis, Pneumoconiosis; Silica
CompletedUniversity of Oklahoma1832019-01-142023-12-06
Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
People with silicosis - Silicosis
CompletedChinese University of Hong Kong3902016-06-012018-07-06
Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Weekly INH / RRT given by DOT - Silicosis, Tuberculosis
Phase 3CompletedHuashan Hospital5662015-03-012020-06-30
Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
Silicosis
UnknownTel-Aviv Sourasky Medical Center1502011-09-012011-04-19
DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)
Silicosis
UnknownTel-Aviv Sourasky Medical Center1502011-09-012011-04-05
Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
Silicosis
CompletedRio de Janeiro State University672010-07-012014-10-23
Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Cells - Silicosis
Phase 1 / Phase 2CompletedWei Yu102010-06-012013-11-25
Safety of Stem Cells Intrabronchial Instillation for Silicosis
Autologous cell transplantation - Chronic and Accelerated Silicosis
Phase 1CompletedUniversidade Federal do Rio de Janeiro52009-08-012015-05-27
Specialized Center of Research in Occupational and Immunologic Lung Disease
Lung Diseases, Obstructive, Asbestosis
CompletedNational Heart, Lung, and Blood Institute (NHLBI)1972-06-012016-05-13

Narrower conditions

Pneumoconiosis (3)  ·  Tuberculosis (3)  ·  Asbestosis (2)  ·  Lung Diseases (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Anthracosis (1)  ·  Behavior (1)  ·  Bronchiectasis (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Hypertension, Pulmonary (1)  ·  Idiopathic Pulmonary Fibrosis (1)  ·  Infections (1)  ·  Latent Tuberculosis (1)  ·  Lung Diseases, Interstitial (1)

Broader conditions

Lung Injury (19)  ·  Occupational Diseases (19)  ·  Respiratory Tract Diseases (19)  ·  Lung Diseases, Interstitial (18)  ·  Lung Diseases (17)  ·  Pneumoconiosis (16)  ·  Actinomycetales Infections (4)  ·  Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Gram-Positive Bacterial Infections (4)  ·  Mycobacterium Infections (4)  ·  Infections (3)  ·  Bronchial Diseases (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)

Interventions

Surveys and Questionnaires (2)  ·  Cell Count (1)  ·  Diagnostic Imaging (1)  ·  Isoniazid (1)  ·  N95 Respirators (1)  ·  Respiratory Function Tests (1)  ·  Spirometry (1)  ·  gp100 Melanoma Antigen (1)  ·  nintedanib (1)  ·  pirfenidone (1)  ·  rifapentine (1)

Sponsors

Tel-Aviv Sourasky Medical Center (2)  ·  The University of Queensland (2)  ·  Centre for Infectious Disease Research in Zambia (1)  ·  Chinese University of Hong Kong (1)  ·  HOHM Foundation (1)  ·  Holdsworth House Medical Practice (1)  ·  Huashan Hospital (1)  ·  Instituto de investigación e innovación biomédica de Cádiz (1)  ·  Johns Hopkins University (1)  ·  National Heart and Lung Institute (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Rio de Janeiro State University (1)  ·  Samuel Hatfield (1)  ·  Universidade Federal do Rio de Janeiro (1)  ·  University of Oklahoma (1)

Countries

Australia (3)  ·  China (3)  ·  United States (3)  ·  Brazil (2)  ·  Israel (2)  ·  Nepal (1)  ·  Rwanda (1)  ·  Spain (1)  ·  Tanzania (1)  ·  Zambia (1)

Top investigators

Daniel Chambers (2)  ·  Yehuda Shwartz, MD (2)  ·  Alastair C Gray, PhD (1)  ·  Antonio Campos Caro, phD (1)  ·  Deborah Yates, A/Prof (1)  ·  Hans Weill (1)  ·  Innocent Kamali (1)  ·  Jad Kebbe, MD (1)  ·  Wenhong Zhang, MD,PhD (1)  ·  William Checkley, MD, PhD (1)

Results publications

PMID 12371452, PMID 17296674, PMID 23778400, PMID 24685414, PMID 26059242, PMID 26400297, PMID 28195659, PMID 28514023, PMID 31770617, PMID 32553881, PMID 33774816, PMID 34042560, PMID 35918725, PMID 40320069, PMID 42481393

NIH funding

D43TW009340 (1), P50HL015092 (1)